The 6th Zurich Immuno-Oncology Symposium will bring together clinicians and scientists across the cancer immunotherapy field to deepen the understanding of cancer, the immune system and immunotherapy.
Virtual
03.02.2022
3.00 - 6.45 pm
3 SGMO
| 3.00 pm | Welcome Matthias Guckenberger, University Hospital Zurich Reinhard Dummer, University Hospital Zurich |
|---|---|
| 3.05 pm | The strength and weakness of neoadjuvant immunotherapy in various cancers Christian Blank – The Netherlands Cancer Institute, Amsterdam |
| 3.35 pm | How to prevent and treat immune related adverse events Lucie Heinzerling, University Hospital Munich |
| 4.05 pm | Merkel cell carcinoma – a prototype virus induced malignancy Selma Ugurel, University Hospital Essen |
| 4.35 pm | Break |
| 5.05 pm | The immunological and metabolic landscape in primary and metastatic liver cancer Mathias Heikenwälder – German Cancer Research Center DKFZ, Heidelberg |
| 5.35 pm | Targeting mitochondrial dynamics for tailoring T cell anti-tumor responses Ping-Chih Ho – Ludwig Cancer Research, Lausanne |
| 6.05 pm | Mobilizing anti-tumor immunity with radiation therapy Fernanda Herrera – CHUV, Lausanne |
| 6.35 pm | Wrap up Matthias Guckenberger, University Hospital Zurich Reinhard Dummer, University Hospital Zurich |
